Invesco Ltd. Crispr Therapeutics Ag Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Invesco Ltd. holds 31,780 shares of CRSP stock, worth $1.29 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

31,780

Previous 32,900 3.4%

Holding current value

$1.29 Million

Previous $1.78 Million 15.93%

% of portfolio

0.0%

Previous 0.0%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	SELL	$44.62 - $62.75 $49,974 - $70,280	-1,120 Reduced 3.4%	31,780 $1.49 Million
Q2 2024 Aug 13, 2024	BUY	$51.17 - $68.18 $68,158 - $90,815	1,332 Added 4.22%	32,900 $1.78 Million
Q1 2024 May 14, 2024	SELL	$60.67 - $89.12 $1.19 Million - $1.75 Million	-19,616 Reduced 38.32%	31,568 $2.15 Million
Q4 2023 Feb 12, 2024	SELL	$38.62 - $72.18 $3.28 Million - $6.13 Million	-84,939 Reduced 62.4%	51,184 $3.2 Million
Q3 2023 Nov 13, 2023	BUY	$45.39 - $59.0 $93,548 - $121,599	2,061 Added 1.54%	136,123 $6.18 Million
Q2 2023 Aug 11, 2023	SELL	$43.47 - $67.77 $140,016 - $218,287	-3,221 Reduced 2.35%	134,062 $7.53 Million
Q1 2023 May 12, 2023	BUY	$41.0 - $56.12 $500,979 - $685,730	12,219 Added 9.77%	137,283 $6.21 Million
Q4 2022 Feb 13, 2023	SELL	$39.19 - $65.67 $42,442 - $71,120	-1,083 Reduced 0.86%	125,064 $5.08 Million
Q3 2022 Nov 14, 2022	SELL	$61.1 - $83.78 $80,102 - $109,835	-1,311 Reduced 1.03%	126,147 $8.24 Million
Q2 2022 Aug 15, 2022	BUY	$43.23 - $73.83 $403,552 - $689,203	9,335 Added 7.9%	127,458 $7.75 Million
Q1 2022 May 16, 2022	BUY	$53.19 - $79.24 $1.41 Million - $2.09 Million	26,428 Added 28.82%	118,123 $7.42 Million
Q4 2021 Feb 14, 2022	SELL	$70.09 - $111.29 $333,418 - $529,406	-4,757 Reduced 4.93%	91,695 $6.95 Million
Q3 2021 Nov 15, 2021	SELL	$110.2 - $156.64 $3.5 Million - $4.98 Million	-31,768 Reduced 24.78%	96,452 $10.8 Million
Q2 2021 Aug 17, 2021	BUY	$100.84 - $161.89 $1.05 Million - $1.69 Million	10,438 Added 8.86%	128,220 $20.8 Million
Q1 2021 May 17, 2021	SELL	$110.72 - $210.04 $20.8 Million - $39.4 Million	-187,564 Reduced 61.43%	117,782 $14.4 Million
Q4 2020 Feb 16, 2021	BUY	$79.67 - $173.23 $13 Million - $28.3 Million	163,412 Added 115.13%	305,346 $46.8 Million
Q3 2020 Nov 16, 2020	SELL	$78.5 - $100.64 $3.34 Million - $4.29 Million	-42,578 Reduced 23.08%	141,934 $11.9 Million
Q2 2020 Aug 14, 2020	SELL	$38.5 - $76.05 $223,107 - $440,709	-5,795 Reduced 3.05%	184,512 $13.6 Million
Q1 2020 May 15, 2020	BUY	$33.68 - $62.53 $1.92 Million - $3.56 Million	56,928 Added 42.68%	190,307 $8.07 Million
Q4 2019 Feb 14, 2020	BUY	$36.68 - $73.13 $3.81 Million - $7.59 Million	103,822 Added 351.26%	133,379 $8.12 Million
Q3 2019 Nov 14, 2019	BUY	$40.99 - $52.56 $1.21 Million - $1.55 Million	29,557 New	29,557 $1.21 Million

Others Institutions Holding CRSP

# of Institutions

490

Shares Held

58M

Call Options Held

1.1M

Put Options Held

1.9M

View Full List

About CRISPR Therapeutics AG

Ticker CRSP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,009,296
Market Cap $3.18B
Description
CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....

More about CRSP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account